FM
Publications
318
Views
147,107
Downloads
30,803
Supervised works
10
Items per page
1 - 318 of 318
Title Published in Access level OA Policy Year Views Downloads
2D echocardiography video to 3D heart shape reconstruction for clinical applicationMedical image analysis
accessLevelPublic
2025 8 8
Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction : a target trial emulation from a real-world cohortEuropean journal of preventive cardiology
accessLevelPublic
2025 1 7
Recruiting medical, dental, and biomedical students as first responders in the immediate aftermath of the COVID-19 pandemic : prospective follow-up studyJMIR medical education
accessLevelPublic
2025 63 114
Left atrial wall shear stress correlates with fibrosis in patients with atrial fibrillationNature cardiovascular research
accessLevelPublic
2025 44 71
Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement : association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trialEuropean journal of preventive cardiology
accessLevelPublic
2025 25 25
Diversité de la cardiologie contemporaineRevue médicale suisse
accessLevelPublic
2024 13 10
A systematic review and meta-analysis of differences between men and women in short-term outcomes following coronary artery bypass graft surgeryScientific reports
accessLevelPublic
2024 165 144
Addressing residual risk beyond statin therapy : New targets in the management of dyslipidaemias - A report from the European Society of Cardiology Cardiovascular Round TableJournal of clinical lipidology
accessLevelRestricted
2024 5 0
Reduced sclerostin expression in human atherosclerotic plaques links to ischemic strokeJournal of the American Heart Association. Cardiovascular and cerebrovascular disease
accessLevelPublic
2024 80 63
Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trialResearch and practice in thrombosis and haemostasis
accessLevelPublic
2024 73 112
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-studyCatheterization and cardiovascular interventions
accessLevelRestricted
2024 5 0
Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromesAtherosclerosis plus
accessLevelPublic
2024 7 9
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndromeEuropean journal of preventive cardiology
accessLevelPublic
2024 60 98
Body temperature, systemic inflammation and risk of adverse events in patients with acute coronary syndromesEuropean journal of clinical investigation
accessLevelPublic
2024 5 8
Window of opportunity for developing effective medical intervention for calcific aortic valve diseaseEuropean heart journal
accessLevelPublic
2024 17 17
Smoking cessation in people with and without diabetes after acute coronary syndromeNicotine & tobacco research
accessLevelPublic
2023 74 21
Effects of SARS-COV-2 infection on outcomes in patients hospitalized for acute cardiac conditions. A prospective, multicenter cohort study (Swiss Cardiovascular SARS-CoV-2 Consortium)Frontiers in cardiovascular medicine
accessLevelPublic
2023 95 23
Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humansCardiovascular research
accessLevelPublic
2023 70 54
Antibody against apolipoprotein-A1, Metabolic-Associated Fatty Liver Diseaseand cardiovascular risk : a translational studyESC (European Society of Cardiology) Congress 2023
2023 3 0
Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromesEuropean heart journal. Acute cardiovascular care
accessLevelPublic
2023 57 146
Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational studyJournal of translational medicine
accessLevelPublic
2023 139 119
« Heart Team » : le cœur de la cardiologieRevue médicale suisse
accessLevelPublic
2023 7 11
Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes : A post hoc analysis of the CAPTURE studyDiabetes, obesity and metabolism
accessLevelPublic
2023 109 203
Enoxaparin for outpatients with COVID-19 : 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trialThrombosis research
accessLevelPublic
2023 101 108
In-hospital initiation of PCSK9 inhibitors in ACS : pros and consEuroIntervention
accessLevelPublic
2023 95 151
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumabPloS one
accessLevelPublic
2022 99 64
A Short Intervention and an Interactive e-Learning Module to Motivate Medical and Dental Students to Enlist as First Responders: Implementation StudyJMIR. Journal of medical internet research
accessLevelPublic
2022 306 223
Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein IResearch and practice in thrombosis and haemostasis
accessLevelPublic
2022 192 280
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after studySwiss medical weekly
accessLevelPublic
2022 72 45
Effectiveness, adherence, and safety of evolocumab in a swiss multicenter prospective observational studyAdvances in therapy
accessLevelPublic
2022 221 200
Combination lipid-lowering therapy as first-line strategy in very high-risk patientsEuropean heart journal
accessLevelRestricted
2022 259 3
The 'ten commandments' for the 2021 ESC Guidelines on CVD preventionEuropean heart journal
accessLevelPublic
2022 122 227
High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD?90th European Atherosclerosis Society (EAS) congress
2022 156 0
Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery diseaseInternational journal of molecular sciences
accessLevelPublic
2022 192 200
Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE) : a single-arm, multicentre, open-label extension of HAUSER-RCTThe Lancet. Diabetes & endocrinology
accessLevelRestricted
2022 93 0
Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society SurveyEuropean journal of preventive cardiology
accessLevelRestricted
2022 203 0
European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of CardiologyEuropean journal of preventive cardiology
accessLevelRestricted
2022 259 0
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trialThe lancet. Haematology
accessLevelPublic
2022 215 231
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle CellsCells
accessLevelPublic
2022 222 298
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort studyPloS one
accessLevelPublic
2022 98 117
2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean journal of preventive cardiology
accessLevelPublic
2022 420 2,289
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis : a European Atherosclerosis Society consensus statementEuropean heart journal
accessLevelPublic
2022 112 401
Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS)-A phase II, randomized, double-blind, multi-center, placebo-controlled trialThe American heart journal
accessLevelRestricted
2022 162 0
Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromesEuropean heart journal
accessLevelRestricted
2022 182 2
Dernières recommandations européennes sur les dyslipidémiesRevue médicale suisse
accessLevelPublic
2022 389 818
Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosisCardiovascular research
accessLevelRestricted
2022 209 0
Inclisiran in primary prevention : reality or fiction ?European heart journal
accessLevelRestricted
2022 130 0
It's never too early to beat your low-density lipoprotein cholesterolArchives of cardiovascular diseases
accessLevelRestricted
2021 152 0
Impact of malignancy on clinical outcomes in patients with acute coronary syndromesInternational journal of cardiology
accessLevelRestricted
2021 185 0
Reduced adrenal stress response in patients on PCSK9 inhibitor therapyAtherosclerosis
accessLevelRestricted
2021 237 0
Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart FailureJournal of clinical medicine
accessLevelPublic
2021 230 87
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trialThe American heart journal
accessLevelRestricted
2021 238 0
Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular diseaseOpen Heart
accessLevelPublic
2021 247 165
Association between self-reported motivation to quit smoking with effectiveness of smoking cessation intervention among patients hospitalized for acute coronary syndromes in SwitzerlandPreventive medicine reports
accessLevelPublic
2021 201 125
Prognostic value of total testosterone levels in patients with acute coronary syndromesEuropean Journal of Preventive Cardiology
accessLevelRestricted
2021 486 3
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsAtherosclerosis
accessLevelPublic
2021 223 57
La réadaptation cardiaque : un programme multidisciplinaire de prévention cardiovasculaire indispensableRevue médicale suisse
accessLevelPublic
2021 292 441
Une baisse du cholestérol LDL de longue durée : enfin le silenceRevue médicale suisse
accessLevelRestricted
2021 291 0
Prognostic value of inflammatory biomarkers and GRACE score for cardiac death and acute kidney injury after acute coronary syndromesEuropean heart journal. Acute cardiovascular care
accessLevelPublic
2021 190 226
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary SyndromesJournal of the American Heart Association
accessLevelPublic
2021 208 124
NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosisInternational journal of molecular sciences
accessLevelPublic
2021 267 205
Lipoprotein(a) levels are not independently associated with endogenous steroid hormone levels, in contrast to other non-genetic and genetic factors: the population-based SKIPOGH studyEuropean heart journal
accessLevelRestricted
2021 239 0
2021 ESC Guidelines on cardiovascular disease prevention in clinical practiceEuropean heart journal
accessLevelRestricted
2021 648 9
Changes of lipoprotein(a) levels with endogenous steroid hormonesEuropean journal of clinical investigation
accessLevelPublic
2021 306 331
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Atherosclerosis
accessLevelPublic
2021 221 294
Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failureReviews in endocrine and metabolic disorders
accessLevelPublic
2021 211 216
Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease89th Europen Society of Atherosclerosis (EAS)
2021 141 0
CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patientsAtherosclerosis
accessLevelPublic
2021 167 51
Impact of COVID-19 on quality of lifee-Journal of Cardiology Practice
accessLevelPublic
2021 211 45
Novel blood biomarkers for a diagnostic workup of acute aortic dissectionDiagnostics
accessLevelPublic
2021 173 96
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episodeSwiss medical weekly
accessLevelPublic
2021 288 119
Air pollution triggers inflammation and cardiovascular events: now is the time to actEuropean heart journal
accessLevelRestricted
2021 161 0
ARN : du prix Nobel au traitement, la cardiologie au devant de la scèneRevue médicale suisse
accessLevelPublic
2021 345 90
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesEuropean journal of preventive cardiology
accessLevelRestricted
2021 163 0
Improving 1-year mortality prediction in ACS patients using machine learningEuropean heart journal. Acute cardiovascular care
accessLevelRestricted
2021 173 1
Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol dietCardiovascular Research
accessLevelPublic
2021 218 132
Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation88th EAS (European Atherosclerosis Society) Congress
2020 61 0
Optimal timing of invasive coronary angiography following NSTEMIJournal of interventional cardiology
accessLevelPublic
2020 237 125
Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trialTrials
accessLevelPublic
2020 73 26
Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid PlaquesInternational Journal of Molecular Sciences
accessLevelPublic
2020 242 118
Efficacy of evolocumab on cardiovascular outcomes in patients with recent myocardial infarction: a prespecified secondary analysis from the FOURIER trialJAMA cardiology
accessLevelPublic
2020 282 378
À propos du bloc-notes: « Statines, la médecine immobile »Revue médicale suisse
accessLevelRestricted
2020 157 0
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskEuropean heart journal
accessLevelPublic
2020 321 831
Cognition After Lowering LDL-Cholesterol With EvolocumabJournal of the American College of Cardiology
accessLevelRestricted
2020 156 0
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyEuropean heart journal. Acute cardiovascular care
accessLevelRestricted
2020 180 0
A Short Intervention Followed by an Interactive E-Learning Module to Motivate Medical Students to Enlist as First Responders: Protocol for a Prospective Implementation StudyJMIR research protocols
accessLevelPublic
2020 313 381
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortInternational journal of cardiology
accessLevelRestricted
2020 221 0
Intravascular lithotripsy to treat an ostial left main coronary artery stenosis due to porcelain aorta in a patient with congenital high-density lipoprotein deficiencyAnatolian Journal of Cardiology
accessLevelPublic
2020 233 140
Au Cœur du Covid-19Revue médicale suisse
accessLevelRestricted
2020 233 0
An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER TrialJAMA cardiology
accessLevelRestricted
2020 150 0
Prognosis of patients with Chronic and Hospital-Acquired Anaemia After Acute Coronary SyndromesJournal of cardiovascular translational research
accessLevelPublic
2020 170 111
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis ProgressionScientific Reports
accessLevelPublic
2020 223 210
Atherosclerotic plaque vulnerability is increased in mouse model of lupusScientific Reports
accessLevelPublic
2020 323 218
Control of cardiovascular risk factors and health behaviors in patients post acute coronary syndromes eligible for protein convertase subtilisin/kexin-9 inhibitorsInternational journal of cardiology
accessLevelRestricted
2020 160 0
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3Thrombosis and Haemostasis
accessLevelRestricted
2020 248 0
Roadmap for the treatment of heart failure patients after hospital discharge: an interdisciplinary consensus paperSchweizerische medizinische Wochenschrift
accessLevelPublic
2020 263 181
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general populationClinical & translational immunology
accessLevelPublic
2020 206 138
Potential of lipoprotein(a)-lowering strategies in treating coronary artery diseaseDrugs
accessLevelRestricted
2020 181 0
Haut les cœurs !Revue médicale suisse
accessLevelPublic
2020 75 57
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrenceJournal of cardiovascular medicine
accessLevelRestricted
2020 217 0
C-terminus apoa-1 mimetic peptides to detect cognate auto-antibodies and reverse HIV-induced foam cell formationAtherosclerosis
accessLevelRestricted
2020 250 0
Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patientsJournal of Thrombosis and Haemostasis
accessLevelRestricted
2020 290 1
Impact of the COVID-19 pandemic on acute coronary syndromesSwiss Medical Weekly
accessLevelPublic
2020 331 155
Determinants of hospital length of stay after transcatheter aortic valve implantation with self-expanding prostheses: a prospective, single centre observational studySwiss medical weekly
accessLevelPublic
2019 96 133
Gender and age differences in outcomes of patients with acute coronary syndromes referred for coronary angiographyCatheterization and Cardiovascular Interventions
accessLevelRestricted
2019 319 0
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy SubjectsJournal of clinical medicine
accessLevelPublic
2019 239 85
Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohortAtherosclerosis
accessLevelRestricted
2019 435 1
Non-linear relationship between anti-apolipoprotein A-1 IgGs and cardiovascular outcomes in patients with acute coronary syndromesJournal of Clinical Medicine
accessLevelPublic
2019 439 181
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromesEuropean Journal of Clinical Investigation
accessLevelRestricted
2019 399 2
Anti-ApoA-1 IgGs in Familial Hypercholesterolemia Display Paradoxical Associations with Lipid Profile and Promote Foam Cell FormationJournal of clinical medicine
accessLevelPublic
2019 239 167
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionPloS one
accessLevelPublic
2019 57 84
Prognostic value of the echocardiographic probability of pulmonary hypertension in patients with acute decompensated heart failureJournal of clinical medicine
accessLevelPublic
2019 399 74
Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patientsJournal of Infection
accessLevelRestricted
2018 580 1
Impact of long distance rowing on biological health: A pilot studyClinical Biochemistry
accessLevelRestricted
2018 563 0
Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillationThe Journal of International Medical Research
accessLevelPublic
2018 425 217
Etat des connaissances en 2018 sur les anticorps anti-PCSK9Revue médicale suisse
accessLevelPublic
2018 233 117
Serum cardiovascular risk biomarkers in pre-pubertal obese childrenEuropean Journal of Clinical Investigation
accessLevelPublic
2018 352 404
Follicular regulatory T cell in atherosclerosisJournal of Leukocyte Biology
accessLevelPublic
2018 353 189
Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart DiseaseInternational Journal of Molecular Sciences
accessLevelPublic
2018 612 238
Activité physique au long cours après un infarctus du myocarde : un défi permanentRevue médicale suisse
accessLevelPublic
2017 660 500
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 PolymorphismsFrontiers in Immunology
accessLevelPublic
2017 470 235
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationArteriosclerosis, Thrombosis, and Vascular Biology
accessLevelRestricted
2017 516 0
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine
accessLevelPublic
2017 522 884
Alamandine abrogates neutrophil degranulation in atherosclerotic miceEuropean Journal of Clinical Investigation
accessLevelPublic
2017 450 586
Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction Role of Differential MicroRNA-378 ExpressionArteriosclerosis, Thrombosis, and Vascular Biology
accessLevelPublic
2017 351 156
Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the KidneyHypertension
accessLevelRestricted
2017 335 0
Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarctionEuropean Heart Journal
accessLevelPublic
2017 351 223
The fear of dying and occurrence of posttraumatic stress symptoms after an acute coronary syndrome: A prospective observational studyJournal of health psychology
accessLevelPublic
2017 552 654
GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na + -Ca 2+ exchanger and endoplasmic reticulum Ca 2+ refillingVascular Pharmacology
accessLevelPublic
2017 330 256
4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viabilityMagnetic Resonance Imaging
accessLevelRestricted
2017 562 2
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophagesVascular pharmacology
2016 558 0
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2016 588 1
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus studyThrombosis and haemostasis
accessLevelRestricted
2016 565 7
Prognostic value of PCSK9 levels in patients with acute coronary syndromesEuropean heart journal
accessLevelRestricted
2016 629 2
Health utility indexes in patients with acute coronary syndromesOpen heart
accessLevelPublic
2016 561 271
Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of StayPloS one
accessLevelPublic
2016 854 387
Myeloid IL-10 receptor signalling as pro-atherogenic factor modulating cholesterol homeostasisThrombosis and haemostasis
accessLevelRestricted
2016 500 2
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individualsNature Genetics
accessLevelRestricted
2016 350 0
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesisThrombosis and haemostasis
accessLevelRestricted
2016 727 1
Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43Cardiovascular research
accessLevelRestricted
2016 695 6
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomesEuropean journal of clinical investigation
accessLevelRestricted
2016 631 6
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosisThrombosis and haemostasis
accessLevelPublic
2016 764 622
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery StenosisMediators of Inflammation
accessLevelPublic
2016 516 192
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial proceduresEuropean Journal of Internal Medicine
accessLevelRestricted
2016 509 1
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2Antioxidants & redox signaling
accessLevelRestricted
2015 601 0
The role of adipocytokines in atherogenesis and atheroprogressionCurrent drug targets
2015 545 0
Update on the role of angiotensin in the pathophysiology of coronary atherothrombosisEuropean journal of clinical investigation
accessLevelRestricted
2015 526 0
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy populationEuropean journal of clinical investigation
accessLevelRestricted
2015 658 0
Use and role of monoclonal antibodies and other biologics in preventive cardiologySchweizerische medizinische Wochenschrift
accessLevelPublic
2015 660 325
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injuryPloS one
accessLevelPublic
2015 674 254
Leptin/adiponectin ratio predicts post-stroke neurological outcomeEuropean journal of clinical investigation
accessLevelRestricted
2015 600 1
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient miceVascular pharmacology
accessLevelRestricted
2015 559 1
Serum osteopontin levels are upregulated and predict disability after an ischaemic strokeEuropean journal of clinical investigation
accessLevelRestricted
2015 667 0
Genetic studies of body mass index yield new insights for obesity biologyNature
2015 628 0
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathwaysEuropean heart journal
accessLevelRestricted
2015 658 2
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte responseVascular pharmacology
accessLevelRestricted
2015 746 0
Editorial: update on inflammatory targets modulating atherogenesisCurrent drug targets
accessLevelRestricted
2015 504 0
Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo studyEuropean journal of anaesthesiology
accessLevelRestricted
2015 552 0
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathwaysVascular pharmacology
accessLevelRestricted
2015 848 4
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathwaysThrombosis and haemostasis
accessLevelRestricted
2015 792 0
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injuryThe journal of sexual medicine
accessLevelRestricted
2015 591 0
Update on the role of neutrophils in atherosclerotic plaque vulnerabilityCurrent drug targets
2015 505 0
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?PloS one
accessLevelPublic
2015 557 348
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic miceVascular pharmacology
accessLevelRestricted
2015 607 0
Mon patient est trop âgé pour une statine : mythes et réalitésRevue médicale suisse
accessLevelRestricted
2015 476 0
Role of matrix metalloproteinases in animal models of ischemic strokeCurrent vascular pharmacology
2015 537 0
Thromboembolic events 7-11 years after catheter ablation of atrial fibrillationPacing and clinical electrophysiology
accessLevelRestricted
2015 596 0
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesAtherosclerosis
accessLevelPublic
2015 786 556
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4Thrombosis and haemostasis
accessLevelRestricted
2015 630 5
Update on the efficacy of statin treatment in acute coronary syndromesEuropean journal of clinical investigation
accessLevelRestricted
2014 598 0
Endothelial Cx40 limits myocardial ischaemia/reperfusion injury in miceCardiovascular research
accessLevelRestricted
2014 723 5
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitisEuropean journal of clinical investigation
accessLevelRestricted
2014 654 0
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic miceThrombosis and haemostasis
accessLevelRestricted
2014 788 0
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a caseWorld journal of clinical cases
accessLevelRestricted
2014 668 0
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionWorld journal of cardiology
accessLevelRestricted
2014 583 0
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patientsEuropean journal of internal medicine
accessLevelRestricted
2014 558 0
La testostérone : un traitement pour la prévention des maladies cardiovasculaires ?Revue médicale suisse
accessLevelRestricted
2014 505 0
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaquesThrombosis and haemostasis
accessLevelRestricted
2014 603 0
Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in miceJournal of cerebral blood flow and metabolism
accessLevelPublic
2014 776 375
Inferior vena cava parameters predict re-admission in ischaemic heart failureEuropean journal of clinical investigation
accessLevelRestricted
2014 618 0
Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosisThrombosis and haemostasis
accessLevelRestricted
2014 650 0
Left atrial dissection after mitral valve replacementEuropean heart journal
accessLevelRestricted
2014 652 0
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosisMediators of inflammation
accessLevelPublic
2014 835 393
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseasesCurrent medicinal chemistry
2014 764 0
Advanced glycation end products play adverse proinflammatory activities in osteoporosisMediators of inflammation
accessLevelPublic
2014 532 584
Angiotensin II receptor antagonists in acute coronary syndromesEuropean journal of clinical investigation
accessLevelRestricted
2014 515 0
Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic strokeThrombosis and haemostasis
accessLevelRestricted
2014 650 0
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndromeThrombosis and haemostasis
accessLevelRestricted
2013 572 0
Pathophysiological role of neutrophils in acute myocardial infarctionThrombosis and haemostasis
accessLevelRestricted
2013 607 0
Discovery and refinement of loci associated with lipid levelsNature genetics
accessLevelRestricted
2013 675 0
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokinesEuropean heart journal
accessLevelRestricted
2013 586 0
Update on the protective molecular pathways improving pancreatic beta-cell dysfunctionMediators of inflammation
accessLevelPublic
2013 697 273
Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serumMediators of inflammation
accessLevelRestricted
2013 534 0
Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitisJournal of periodontal research
accessLevelRestricted
2013 774 1
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarctionAntioxidants & redox signaling
accessLevelPublic
2013 781 802
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomyThrombosis and haemostasis
accessLevelRestricted
2013 737 1
Role of matrix metalloproteinase-8 in atherosclerosisMediators of inflammation
accessLevelPublic
2013 539 269
Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesityMediators of inflammation
accessLevelPublic
2013 561 258
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in miceThrombosis and haemostasis
accessLevelRestricted
2013 755 0
Pathophysiological role of the renin-angiotensin system on erectile dysfunctionEuropean journal of clinical investigation
accessLevelPublic
2013 531 710
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndromeMediators of inflammation
accessLevelPublic
2013 551 205
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinomaWorld journal of gastroenterology
accessLevelRestricted
2013 580 0
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetesMediators of inflammation
accessLevelPublic
2013 518 425
Inflammation is a key pathophysiological feature of metabolic syndromeMediators of inflammation
accessLevelPublic
2013 537 200
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemiaThe journal of sexual medicine
accessLevelRestricted
2013 543 0
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseasesThrombosis and haemostasis
accessLevelRestricted
2013 500 0
Update on evidence for treatment with ranolazine in stable anginaSchweizerische medizinische Wochenschrift
accessLevelRestricted
2013 497 0
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in miceJournal of cerebral blood flow and metabolism
accessLevelRestricted
2013 725 0
Role of the renin-angiotensin system on abdominal aortic aneurysmsEuropean journal of clinical investigation
accessLevelRestricted
2013 500 0
Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic miceClinical & developmental immunology
accessLevelRestricted
2013 570 0
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2013 651 0
Cardiopathies congénitales de l'âge adulte: nouvelle population de patients, prise en charge multidisciplinaireRevue médicale suisse
accessLevelRestricted
2013 554 0
The vulnerable coronary plaque: update on imaging technologiesThrombosis and haemostasis
accessLevelRestricted
2013 450 0
Lack of association between connexin40 polymorphisms and coronary artery diseaseAtherosclerosis
accessLevelRestricted
2012 596 5
Serum resistin and inflammatory and endothelial activation markers in obese adolescentsThe Journal of pediatrics
accessLevelRestricted
2012 625 0
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events studyCirculation
accessLevelPublic
2012 731 55
Shear stress modulates the expression of the atheroprotective protein Cx37 in endothelial cellsJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2012 781 7
Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individualsMediators of inflammation
accessLevelPublic
2012 653 284
Manganese kinetics demonstrated double contrast in acute but not in chronic infarction in a mouse model of myocardial occlusion reperfusionNMR in biomedicine
accessLevelRestricted
2012 646 0
Coronary Vasomotor Control in Obesity and Morbid ObesityJACC. Cardiovascular imaging
accessLevelPublic
2012 763 656
Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injuryCurrent pharmaceutical biotechnology
accessLevelRestricted
2012 406 0
Statins in the treatment of acute ischemic strokeCurrent pharmaceutical biotechnology
accessLevelRestricted
2012 513 0
Role of renin-angiotensin system in inflammation, immunity and agingCurrent pharmaceutical design
2012 523 0
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic MyocardiumCurrent signal transduction therapy
accessLevelRestricted
2012 585 0
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injuryEuropean journal of clinical investigation
accessLevelRestricted
2012 629 0
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancerWorld journal of gastroenterology
accessLevelRestricted
2012 502 0
Role of cytokines and chemokines in non-alcoholic fatty liver diseaseWorld journal of gastroenterology
accessLevelRestricted
2012 391 1
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in miceEuropean heart journal
accessLevelRestricted
2012 688 1
Statins and stent thrombosisSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 482 0
Matching between regional coronary vasodilator capacity and corresponding circumferential strain in individuals with normal and increasing body weightJournal of nuclear cardiology
accessLevelPublic
2012 697 297
Update on the role of cannabinoid receptors after ischemic strokeMediators of inflammation
accessLevelRestricted
2012 512 1
Curing by Burning: What to expect from renal denervation in the treatment of arterial hypertensionKardiovaskuläre Medizin
accessLevelRestricted
2012 614 0
Elevated E-selectin and diastolic blood pressure in diabetic childrenEuropean journal of clinical investigation
accessLevelRestricted
2012 650 0
Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarctionJournal of internal medicine
accessLevelRestricted
2012 670 2
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaquesEuropean heart journal
accessLevelRestricted
2012 742 0
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiologyExpert review of cardiovascular therapy
2012 591 0
The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseasesThrombosis and haemostasis
accessLevelRestricted
2012 437 0
Fondaparinux versus enoxaprin in the management of acute coronary syndromes in Switzerland: A cost comparison analysisSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 519 0
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activationCirculation
accessLevelRestricted
2012 509 0
Molecular imaging of matrix metalloproteinases in atherosclerotic plaquesThrombosis and haemostasis
accessLevelRestricted
2012 486 0
High time-resolved cardiac functional imaging using temporal regularization for small animal on a clinical 3T scannerIEEE transactions on biomedical engineering
accessLevelRestricted
2012 619 0
Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerabilityThrombosis and haemostasis
accessLevelRestricted
2012 794 0
Inflammatory cardiovascular risk biomarkers: update on novelties and limitationsMediators of inflammation
accessLevelRestricted
2012 509 0
Antiapolipoprotein A-1 IgG chronotropic effects require nongenomic action of aldosterone on L-type calcium channelsEndocrinology
accessLevelRestricted
2012 708 0
Sélection et suivi prétransplantation des patients candidats à la greffe cardique en Suisse romandeRevue médicale suisse
accessLevelRestricted
2011 615 0
Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomicsThrombosis and haemostasis
accessLevelRestricted
2011 724 0
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerabilityEuropean heart journal
accessLevelRestricted
2011 674 2
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndromeAmerican journal of physiology: endocrinology and metabolism
accessLevelRestricted
2011 666 0
Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practiceJournal of medical genetics
accessLevelRestricted
2011 673 0
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesityEuropean heart journal
accessLevelRestricted
2011 671 0
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signallingEuropean journal of clinical investigation
accessLevelRestricted
2010 566 0
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic miceJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2010 735 0
Un projet multicentrique suisse pour améliorer la prévention et la récidive après un syndrome coronarien aiguRevue médicale suisse
2010 649 0
In vivo labelling of resting monocytes in the reticuloendothelial system with fluorescent iron oxide nanoparticles prior to injury reveals that they are mobilized to infarcted myocardiumEuropean heart journal
accessLevelRestricted
2010 545 0
Novel treatment strategy with direct renin inhibition against heart failurePanminerva Medica
2010 488 0
La cardiologie dans le rythmeRevue médicale suisse
2010 493 0
Le clopidogrel et ses différents sets: existe-t-il une pertinence clinique?Revue médicale suisse
2010 609 0
Stairs instead of elevators at workplace: cardioprotective effects of a pragmatic interventionEuropean journal of cardiovascular prevention & rehabilitation
accessLevelRestricted
2010 1,022 0
New evidence for nicotinic acid treatment to reduce atherosclerosisExpert review of cardiovascular therapy
2010 1,041 0
Combined evaluation of myocardial perfusion and coronary morphology in the identification of subclinical CAD. Radiation exposure of 13N-ammonia PET/CTNuclear-Medizin
2010 648 0
High-Throughput Phospholipidic Fingerprinting by Online Desorption of Dried Spots and Quadrupole-Linear Ion Trap Mass Spectrometry: Evaluation of Atherosclerosis Biomarkers in Mouse PlasmaAnalytical chemistry
accessLevelRestricted
2010 631 0
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS)Sleep & breathing
accessLevelPublic
2010 605 386
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritisArthritis and rheumatism
accessLevelRestricted
2010 903 3
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2010 640 0
Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarctionEuropean heart journal
accessLevelRestricted
2010 705 0
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE studyJournal of thrombosis and haemostasis
accessLevelRestricted
2010 605 0
Myocardial infarction quantification with Manganese-Enhanced MRI (MEMRI) in mice using a 3T clinical scannerNMR in biomedicine
accessLevelRestricted
2010 591 2
Structural epicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CTJournal of nuclear cardiology
accessLevelPublic
2010 674 235
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic strokeStroke
accessLevelRestricted
2010 664 0
Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcificationCritical pathways in cardiology
2010 746 0
Prehospital emergency physician activation of interventional cardiology team reduces door-to-balloon time in ST-elevation myocardial infarctionSchweizerische medizinische Wochenschrift
accessLevelPublic
2010 610 152
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistanceCurrent vascular pharmacology
2009 529 0
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusionJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2009 779 0
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndromeDiabetes, obesity & metabolism
accessLevelRestricted
2009 579 0
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosisRheumatology
accessLevelRestricted
2009 659 0
Ezetimibe/simvastatinExpert opinion on drug safety
accessLevelRestricted
2009 533 0
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular riskPharmacological Reports
2009 546 0
Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysisCirculation
accessLevelRestricted
2009 630 0
Noninvasive stress testing of myocardial perfusion defects: head-to-head comparison of thallium-201 SPECT to MRI perfusionJournal of nuclear cardiology
accessLevelPublic
2009 655 409
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS
accessLevelRestricted
2009 662 0
Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsinClinical and experimental pharmacology & physiology
accessLevelRestricted
2009 715 0
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesMediators of inflammation
accessLevelRestricted
2009 608 0
Atherosclerosis is an inflammatory diseaseSeminars in immunopathology
accessLevelPublic
2009 844 207
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytesRheumatology
accessLevelRestricted
2009 658 0
Update on statin-mediated anti-inflammatory activities in atherosclerosisSeminars in immunopathology
accessLevelPublic
2009 515 472
Suivi du patient après transplantation cardiaque : monitoring et adaptation de l'immunosuppressionRevue médicale suisse
accessLevelRestricted
2009 621 0
Obstructive sleep apnea and atherosclerosisProgress in cardiovascular diseases
accessLevelRestricted
2009 643 0
Swimming prevents vulnerable atherosclerotic plaque development in hypertensive 2-kidney, 1-clip mice by modulating angiotensin II type 1 receptor expression independently from hemodynamic changesHypertension
accessLevelRestricted
2009 589 0
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosisAtherosclerosis
accessLevelRestricted
2009 635 0
Percutaneous retrieval of intravascular and intracardiac foreign bodies with a dedicated three-dimensional snare: a 3-year single center experienceCatheterization and cardiovascular interventions
accessLevelRestricted
2009 607 0
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injuryThrombosis and haemostasis
2009 587 0
Statins, ACE inhibitors and ARBs in cardiovascular diseaseBaillière's best practice & research. Clinical endocrinology & metabolism
accessLevelRestricted
2009 606 0
Stair use for cardiovascular disease preventionEuropean journal of cardiovascular prevention & rehabilitation
2009 653 0
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathwaysJournal of Biomedicine and Biotechnology
accessLevelRestricted
2009 535 0
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsivenessThrombosis research
accessLevelRestricted
2008 632 0
Cannabinoid receptors in acute and chronic complications of atherosclerosisBritish journal of pharmacology
accessLevelRestricted
2008 627 0
A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathyHuman mutation
accessLevelRestricted
2008 756 0
Renin-angiotensin system blockade and contrast-induced renal toxicityJN. Journal of Nephrology
2008 606 0
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instabilityMediators of inflammation
accessLevelPublic
2008 595 521
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathwaysCellular signalling
accessLevelRestricted
2008 707 0
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytesJournal of leukocyte biology
accessLevelRestricted
2008 643 0
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factorClinical interventions in aging
accessLevelPublic
2008 588 225
Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndromeClinical science
accessLevelRestricted
2008 772 9
PARP1 is required for adhesion molecule expression in atherogenesisCardiovascular research
accessLevelRestricted
2008 640 184
The role of the endocannabinoid system in atherosclerosisJournal of neuroendocrinology
accessLevelRestricted
2008 626 0
Emerging Roles for Connexins in HypertensionCurrent hypertension reviews
2008 645 0
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathwaysAmerican journal of physiology. Heart and circulatory physiology
accessLevelRestricted
2008 627 0
Adiponectin and adaptive immunity: linking the bridge from obesity to atherogenesisCirculation research
accessLevelRestricted
2008 590 0
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2008 693 0
Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaquesThrombosis and haemostasis
accessLevelPublic
2007 613 227
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
accessLevelRestricted
2007 611 0
Soluble CD40 ligand in prediction of acute severe pancreatitisWorld journal of gastroenterology
accessLevelPublic
2006 827 447
L'apport de la génétique moléculaire en cardiologie clinique : l'exemple de la cardiomyopathie hypertrophiqueRevue médicale suisse
accessLevelRestricted
2005 575 1
Late cardiac tamponade after percutaneous closure of a patent foramen ovaleEuropean journal of echocardiography
accessLevelPublic
2005 553 319
Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemiaCritical care medicine
accessLevelRestricted
2004 608 1
Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular diseaseJournal of autoimmunity
accessLevelRestricted
2004 540 0
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient miceCirculation
accessLevelRestricted
2003 563 1
Cd40 ligand-deficient mice are protected against cerulein-induced acute pancreatitis and pancreatitis-associated lung injuryGastroenterology
accessLevelRestricted
2001 790 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack